Inactive Instrument
Medicure Inc Stock Toronto S.E.
Stocks
MPH
CA58469E4085
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 12.52M 8.84M 7.73M 7.15M 6.67M 836M 12.62M 84.93M 33.05M 411M 33.2M 32.48M 1.43B | P/E 2024 |
-8.8x | P/E 2025 | -1.68x |
|---|---|---|---|---|---|
| Enterprise Value | 9.58M 6.76M 5.91M 5.47M 5.1M 639M 9.65M 64.97M 25.28M 314M 25.4M 24.85M 1.09B | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.31x |
| Free-Float |
73.4% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Medicure Inc
| 1 day | -5.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Friesen
CEO | Chief Executive Officer | 79 | 15/09/1997 |
Haaris Uddin
DFI | Director of Finance/CFO | - | 01/06/2022 |
Reuben Saba
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Albert Friesen
CHM | Chairman | 79 | 15/09/1997 |
Arnold Naimark
BRD | Director/Board Member | 92 | 28/02/2000 |
Brent Fawkes
BRD | Director/Board Member | 56 | 22/01/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.23% | +0.16% | - | - | 8.83M | ||
| +2.87% | +4.57% | +70.82% | +119.22% | 55.19B | ||
| +4.00% | +7.14% | +63.67% | +68.77% | 45.75B | ||
| +0.36% | +0.26% | -11.62% | -15.16% | 22.98B | ||
| +3.28% | +1.19% | -6.46% | +384.83% | 20.76B | ||
| -0.26% | -1.09% | +27.55% | -18.57% | 16.26B | ||
| +1.16% | +3.86% | +22.36% | -36.42% | 15.42B | ||
| -1.43% | -3.35% | +18.11% | +157.67% | 13.05B | ||
| +3.30% | +15.38% | +133.24% | +273.89% | 12.45B | ||
| -5.63% | -5.49% | +21.79% | - | 12.37B | ||
| Average | +0.25% | +3.15% | +37.72% | +116.78% | 23.8B | |
| Weighted average by Cap. | +1.80% | +2.66% | +43.77% | +108.85% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 21.91M 15.47M 13.52M 12.5M 11.67M 1.46B 22.07M 149M 57.81M 719M 58.08M 56.82M 2.5B | 28.86M 20.37M 17.8M 16.47M 15.37M 1.93B 29.07M 196M 76.14M 947M 76.5M 74.84M 3.29B |
| Net income | -1.04M -734K -641K -593K -553K -69.33M -1.05M -7.05M -2.74M -34.09M -2.75M -2.69M -118M | -7.1M -5.01M -4.38M -4.05M -3.78M -474M -7.15M -48.13M -18.73M -233M -18.81M -18.41M -809M |
| Net Debt | -6.32M -4.46M -3.9M -3.61M -3.36M -422M -6.36M -42.84M -16.67M -207M -16.75M -16.38M -720M | -2.94M -2.08M -1.82M -1.68M -1.57M -196M -2.97M -19.97M -7.77M -96.58M -7.8M -7.64M -336M |
Employees
-

















